) has shown multiple pharmacological activities and been considered as one of the most promising approaches for fatigue treatment. However, 20(R)-Rg3 has a low bioavailability after oral administration in human due to the first-pass effect. Recently, nasal route has gained increasing interest as it can avoid first-pass effect for its lower enzymatic activity compared with the gastrointestinal tract and liver. In order to provide an animal experimental evidence of 20(R)-Rg3 intranasal administrated preparation, the antifatigue effect of 20(R)-Rg3 after intranasal administration was investigated. Two weeks after 20(R)-ginsenoside Rg3 was administrated intranasally to mice at three different doses, the anti-fatigue effect of 20(R)-Rg3 was evaluated by the weight-loaded swimming test and biochemical parameters related to fatigue, such as serum urea nitrogen (SUN), lactic dehydrogenase (LDH), superoxide dismutase (SOD), malondialdehyde (MDA), blood lactic acid (LA) and hepatic glycogen. The results showed that compared with the negative control group, the intermediate-dose and the high-dose groups significantly prolonged the weight-loaded swimming time (pϽ0.05; pϽ0.01), and also increased the hepatic glycogen levels (pϽ0.05); SUN levels were decreased considerably in three 20(R)-Rg3-treated groups (pϽ0.01). In addition, the low-dose group obviously decreased the content of blood LA (pϽ0.05). However, the levels of LDH, SOD and MDA did not show a significant change. Our results predicted a benefit of 20(R)-Rg3 as an anti-fatigue treatment by intranasal administration. The mechanism was related to the increase of the storage of hepatic glycogen, and the decrease of the accumulation of metabolite such as lactic acid and serum urea nitrogen.
Panax ginseng has been frequently used in traditional Chinese medicine to treat many disorders, such as debility, ageing, stress, diabetes and insomnia.
1) The major biological active components of ginseng are ginsenosides.
2) 20(R)-Ginsenoside Rg3 (3b,12b,20(R)-dihydroxydammar-24-ene-3-O-[b-D-glucopyranosyl(1→2)-b-D-glucopyranoside]), a minor ginsenoside from the Panax ginseng, has shown multiple pharmacological activities, including anti-tumor, 3) immunity enhancement 4) and memory improvement. 5) However, the plasma concentration of 20(R)-ginsenoside Rg3 (20(R)-Rg3) after oral administration in human is very low. Pang et al. 6) obtained some human pharmacokinetic (PK) parameters, including C max of (16.00Ϯ6.00) ng/ml and t max of (0.66Ϯ0.10) h at 3.2 mg/kg from the oral experiments. The short half-life and low plasma concentration of 20(R)-Rg3 from the study indicated that 20(R)-Rg3 might be metabolized quickly after oral administration. Recently, interest arises from different possible advantages presented by the nasal cavity, 7) such as: the epithelium with a relatively large surface area available for drug absorption, the porous endothelial basement membrane, the direct transport of absorbed drugs into the systemic circulation thereby avoiding the first-pass effect in oral administration, the lower enzymatic activity compared with the gastrointestinal tract and the liver, the convenience for administration when there is no water. For all these reasons the nasal route can be considered as a useful alternative both to parenteral and oral routes. 8, 9) However, no reports on the anti-fatigue effect of 20(R)-Rg3 by intranasal administration were found. In order to provide an animal experimental evidence of 20(R)-Rg3 intranasal administrated preparation, in this study, the anti-fatigue effect of 20(R)-Rg3 after intranasal administration was investigated. Methods. Animal Grouping and Administration Mice weighed before experiment, were divided into 4 groups at random (30 mice/group), including one low-dose group (0.05 mg/kg), one intermediate-dose group (0.1 mg/kg), one high-dose group (0.5 mg/kg), and one negative control group (normal saline). The dose range was determined by preliminary tests and previous studies. 10) All the mice were administrated intranasally with 10 ml of drug solution per day via a transferpettor, 5 ml each nostril.
MATERIALS AND METHODS

Materials. Animals
Body Weight Change Changes in body weight of the mice were observed during initial and terminal stages of the test. One hundred and twenty male mice were used for the following tests performed in a randomized double-blind manner.
Weight-Loaded Swimming Test 11) Briefly, 30 min after the last intranasal administration, the mice (10 mice per group) were dropped individually into an acrylic plastic pool (90ϫ45ϫ45 cm) filled with fresh water maintained at 30Ϯ 1°C, approximately 35 cm deep so that mice could not support themselves by touching the bottom with their tails.
A lead block (5% of body weight) was loaded on the tail root of the mice. The total swimming time of mice was calculated from the moment they were dropped into the water till they were completely exhausted as evidenced by sinking into water and drowning.
Measurement of the Contents of SUN, LDH, Hepatic Glycogen, SOD and MDA 12) Thirty minutes after the last administration, the mice (10 mice per group) were forced to swim for 90 min without weight loading, after 60 min of recess, the mice were anesthetized with ether and whole blood samples were collected in tubes by heart puncture. Blood samples were placed for about 1 h at 4°C and centrifuged for 10 min at a speed of 3000 rpm. The supernatant was collected and contents of SUN and LDH were analyzed with commercial kits. In addition, immediately after the blood had been collected, the liver was dissected out quickly from the mice, washed with physiological saline and dried with absorbent paper. Then the content of hepatic glycogen, SOD and MDA was analyzed.
Measurement of the Content of Blood LA Thirty minutes after the last administration, 20 ml of blood was collected from the mice with a capillary tube using the retroorbital bleeding method, 13) then mice were forced to swim for 10 min without weight loading, blood was collected immediately after and 20 min after forced swimming, respectively.
12)
The blood LA levels were analyzed with commercial kits. Then the variance of blood LA after swimming was caculated.
14)
Statistical Analysis Results were expressed as the meanϮstandard error (S.E.). Firstly, the data were analyzed by homogeneity test for variance. If the data were homoscedasticity, the significance of the mean difference was determined by one-way ANOVA, followed by a LSD-t test for multigroup comparisons. Otherwise, it was determined by Tamhane's T2 test. All statistical analyses were performed using SPSS v10.0 statistical analysis software. A value of pϭ0.05 was considered to indicate statistical significance.
RESULTS AND DISCUSSION
Effects on Body Weight Change
The results were shown in Table 1 . The one-way ANOVA results indicated that there were no significant differences in the body weight of the mice in the 20(R)-Rg3 groups, in comparison with the negative control group during initial and terminal stages in this test (Fϭ0.708, pϭ0.549 (Ͼ0.05) ).
Effects on Weight-Loaded Swimming Test The results
were shown in Fig. 1 ming The results were shown in Table 3 . According to the one-way ANOVA and LSD-t test, compared with the negative control, 20(R)-Rg3 administrated groups could reduce the variance of blood LA after swimming in some extent, especially in the low-dose group, the difference was significant (pϭ0.010 (Ͻ0.05)).
CONCLUSION
Fatigue is one of the most frequent physiological reactions. It is well accepted that the most important physiological effect of fatigue is on the energy metabolism of muscular activity, and the improvement of exercise endurance is the most powerful representation of anti-fatigue enhancement. 15) The anti-fatigue activity of 20(R)-Rg3 in the present study is measured by a weight-loaded swimming test, which is accepted as a proper experimental exercise model in previous researches.
16 ) The length of the swimming time shows the degree of fatigue. 17) In addition, SUN, lactic acid and hepatic glycogen are representative blood biochemical parameters related to fatigue. SUN, the product of energy metabolism when moving, is a sensitive index to evaluate the bearing capability when human bodies suffer from a physical load. There is a positive correlation between the urea nitrogen in vivo and the exercise tolerance. In other words, the worse the body is adapted for exercise tolerance, the more significantly the urea nitrogen level increases. 18) The muscle produces plenty of lactic acid when it obtains enough energy from anaerobic glycolysis almost at the same time when doing high-intensity exercise. Furthermore, the increase of lactic acid level will bring about a reduction of pH in muscle tissue and blood, and also induce many side effects of various biochemical and physiological processes. 19) Therefore, rapid removal of lactic acid is beneficial to relieving fatigue. Serum LDH is known to be accurate indicators of muscle damage. 20, 21) It catalyzes lactic acid into pyruvate, thereby reduces the accumulation of lactic acid in muscle. Liver is the direct tissue for energy conservation and utilization.
The liver converts lactate back to glycogen and releases glycogen into the blood. Energy for exercise is derived initially from the breakdown of glycogen, and later from circulation glycogen released by the liver and from non-esterified fatty acids. 22) So increasing the hepatic glycogen storage conduces to enhancing the endurance capacity and locomotory capacity.
In present study, the results showed that compared with the negative group, intranasally administrated 20(R)-Rg3 had no significant difference in body weights of mice. But 20(R)-Rg3 in the high-dose and the intermediate-dose groups prolonged the weight-loaded swimming time in mice (pϽ0.05, pϽ0.01) and the hepatic glycogen level was also increased in these two groups (pϽ0.05, pϽ0.05). 20(R)-Rg3 in the three groups reduced the SUN level obviously (pϽ0.01). In addition, in 20(R)-Rg3 groups, the variance of lactic acid after swimming could be reduced to some extent, especially in the low-dose administrated group where the difference was significant (pϽ0.05). However, the effects on the LDH, SOD and MDA levels had no significant differences.
The anti-fatigue effect of ginsenoside Rg3 is not dose-dependent. It might be because the influence of ginsenosides on central nervous system has a two-way effect, which is shown by the fact that ginsenoside Rb had a sedative effect on central nervous system, while the ginsenoside Rg, especially in the lower dose, had an exciting effect.
23) The experiment results showed that medium-dose (0.1 mg/kg) and high-dose (0.5 mg/kg) of Rg3 could significantly prolong the weightloaded swimming time of mice, but the difference between the two dose groups was not significant (pϭ0.30 (Ͼ0.05)). And three doses of Rg3 could significantly decrease the SUN level, however, there were no significant differences between each two dose groups(high-dose and medium-dose: pϭ0.76 (Ͼ0.05); high-dose and low-dose: pϭ0.59 (Ͼ0.05); mediumdose and low-dose: pϭ0.43 (Ͼ0.05)). The hepatic glycogen levels were significantly increased in medium-and high-dose groups, but the differences between these two groups were not significant (pϭ0.77 (Ͼ0.05)). All the results indicated that the anti-fatigue effect of ginsenoside Rg3 was not dosedependent. Relevant references were attached.
In conclusion, the present results suggest that intranasal administration of 20(R)-ginsenoside Rg3 shows an anti-fatigue effect. The intranasal administration route may have a potential application prospect. Data are meanϮS.E. * pϽ0.05, compared with negative control. Saline was given to mice as a negative control. Ten mice were observed and tested for each group during the experimental period. a) Variance of lactic acidϭ0.5ϫ(lactic acid level before swimmingϩlactic acid level 0 min after swimming)ϫ10ϩ0.5ϫ(lactic acid level 0 min after swimmingϩlactic acid level 20 min after swimming). 12) 
